- Contact Us Now: (202) 589-1834 Tap Here to Call Us
FTC Requires Divestitures of Ambulatory Surgery Centers to Clear Ascension’s $3.9 Billion Acquisition of AmSurg
On June 2, 2026, the Federal Trade Commission issued a complaint and accepted a proposed consent order requiring Ascension Health Alliance to divest seven ambulatory surgery centers as a condition of completing its approximately $3.9 billion acquisition of AmSurg LLC. The Commission later finalized the order on August 25, 2026, after a public comment period, by a 2-0 vote. The remedy preserves competition for certain outpatient surgical services in five metropolitan areas and continues the FTC’s practice of using targeted structural divestitures to resolve local overlaps in healthcare provider mergers.
The Transaction and Competitive Concerns
Ascension is a national nonprofit health system. AmSurg, a subsidiary of Ambulatory Topco LLC, operates more than 250 ambulatory surgery centers across 34 states and provides outpatient surgical services ranging from cataract surgeries to colonoscopies. The proposed combination would have united two significant providers of these services.
The FTC’s investigation identified competitive concerns in the Nashville, Tennessee; Panama City, Florida; Tulsa, Oklahoma; Waco, Texas; and Wichita, Kansas metropolitan areas for certain outpatient procedures performed by gastroenterologists, ophthalmologists, and orthopedists. The complaint alleged that the acquisition would limit competition for these services, increasing the likelihood of higher prices for patients while also threatening quality of care and innovation. The agency worked in collaboration with the offices of the attorneys general of Florida, Oklahoma, and Tennessee.
The Divestiture Remedy
Under the consent order, Ascension must divest seven AmSurg ambulatory surgery centers covering the facilities in the relevant markets where the transaction would otherwise threaten competition. Six of the centers are being divested to SC Affiliates, an experienced national operator of ambulatory surgery centers. The seventh center, in Panama City, is being divested to Florida Gastroenterology Center, a physician group that previously held a minority stake in the facility and will assume full ownership.
The order also requires Ascension, Ambulatory Topco, and AmSurg to provide transition assistance for up to one year, protect confidential information, maintain the viability of the divested assets until transfer, and refrain from interfering with employment relationships at the facilities. An independent monitor will oversee compliance with the divestiture and transition obligations. In addition, for a period of ten years, Ascension must provide the Commission with prior notice of any acquisition of ambulatory surgical centers in the metropolitan areas surrounding the divested facilities.
Bureau of Competition Director Daniel Guarnera stated that access to quality surgical care at an affordable price is critically important and that the divestitures will help preserve a competitive market so patients can obtain the care they need at a fair price.
Implications
The Ascension-AmSurg resolution illustrates the FTC’s continued focus on local market effects in healthcare provider transactions, even when the overall deal is large and involves a national footprint. By requiring divestiture of the specific facilities that created overlaps in the affected metros, the agency restored the pre-merger competitive dynamic while allowing the remainder of the acquisition to proceed. The inclusion of a ten-year prior-notice obligation further extends oversight in the relevant local markets. For health systems and ambulatory surgery center operators considering combinations, the case reinforces that even modest geographic and service-line overlaps can trigger scrutiny and that a pre-negotiated structural remedy with capable buyers remains a viable path to clearance. The final order, approved after public comment, confirms that this approach continues under the current Commission.
Andre Barlow
abarlow@dbmlawgroup.com






